Ulteriori informazioni
The book explores the latest advancements in medical and life sciences, revealing the transformative potential of biosensors and aptamers in combating cancer. These cutting-edge technologies revolutionize diagnosis with unprecedented accuracy and early detection of cancer.
The chapters cover advancements in targeted therapy, where aptamers deliver personalized treatments with remarkable precision, minimizing side effects and maximizing efficacy. It highlights real-world applications, success stories, and the pursuit of more effective and humane cancer diagnosis and treatment.
The book is intended for clinicians and students.
Sommario
1. Introduction to Biosensors and Aptamers: A New Era in Cancer Diagnosis and Treatment.- 2. The Biology of Cancer: Understanding the Disease and Its Challenges.- 3. Aptamers: A Novel Class of Targeted Therapeutics.- 4. Role of Biosensors in Transforming Cancer Diagnostics.- 5. Aptamer-Based Biosensors for Cancer Diagnosis.- 6. Targeted Cancer Therapy with Aptamers: A Review on the Current State.- 7. Aptamer-Based Cancer Diagnosis: Emerging updates.- 8. Designing Aptamers for Cancer Diagnosis and Therapy.- 9. Aptamer-Based Biosensors for Cancer Biomarker Detection.- 10. Aptamer-Based Biosensors for Cancer Imaging.- 11. Aptamer-Based Biosensors for Cancer Therapy Monitoring.- 12. Challenges and Limitations in Aptamer-Based Cancer Diagnosis and Therapy.- 13. Future Directions in Aptamer-Based Cancer Diagnosis and Therapy.- 14. Regulatory Frameworks and Intellectual property rights (IPR) for Aptamer-Based Cancer Diagnosis and Therapy.
Info autore
Dr. Shriyansh Srivastava holds a B. Pharmacy degree from Dr. A.P.J. Abdul Kalam Technical University, Lucknow, Uttar Pradesh, India, and an M. Pharmacy (Pharmacology) degree from ISF College of Pharmacy, Moga, Punjab, India. PhD in Pharmacology & Clinical Research at Delhi Pharmaceutical Sciences and Research University, New Delhi, India. Shriyansh has accumulated three years of research experience, with expertise in cancer pharmacology and infectious diseases. He has an impressive publication record with over 60+ research/review articles in prestigious international journals, including the Lancet series, where his highest impact factor is 38.2 in Lancet Microbes, contributing to a cumulative impact factor of 220+. Additionally, he has published two patents, authored 15 book chapters, and is currently editing seven books under publishers such as Elsevier, Wiley, Springer Nature, and Taylor & Francis. His academic and scientific achievements establish him as a highly accomplished pharmacologist.
Dr. Sachin Kumar, M.S. (Pharm), Ph.D., is an Assistant Professor at Delhi Pharmaceutical Sciences and Research University in New Delhi, India. Dr. Kumar holds a degree in pharmacy from Uttar Pradesh Technical University, Lucknow, Uttar Pradesh, and a Master of Sciences (Pharm) from the National Institute of Pharmaceutical Education and Research, Guwahati, Assam. His research interests include diagnosis, biomarkers, meta-analysis, and pharmacoeconomic analysis. He has authored 21 peer-reviewed papers and 3 book chapters in pharmaceutical sciences.
Dr. Sathvik is an Associate Dean and Professor at RAK College of Pharmacy. He holds a Ph.D. in Clinical Pharmacy and has 25 years of experience in teaching and practicing clinical pharmacy in India, Malaysia, and the UAE. His research interests include medication safety, pharmacovigilance, pharmacoepidemiology, renal and psychiatry, clinical pharmacy, and artificial intelligence. Dr. Sathvik has published over 80 research papers in national and international journals and serves as a reviewer for various pharmacy practice-related journals.
Dr. Malakpogu Ravindra Babu is a Professor in the Department of Pharmaceutics at Galgotias University, India. With over 14 years of experience, his research focuses on minimally invasive drug delivery systems such as microneedles, iontophoresis, and transdermal patches. He has supervised numerous M. Pharm and B. Pharm projects and serves as a reviewer for several reputable journals.
Professor SK Abdul Rahaman is a Professor and Dean of the Department of Pharmacy at Galgotias University in India. With 22 years of teaching and research experience, he has published 113 research articles, holds 22 patents, and has received grants totaling 1.4 Crore from various organizations. Additionally, he has been honored with 22 awards, supervised numerous student projects, and organized 76 national/international events.
Riassunto
The book explores the latest advancements in medical and life sciences, revealing the transformative potential of biosensors and aptamers in combating cancer. These cutting-edge technologies revolutionize diagnosis with unprecedented accuracy and early detection of cancer.
The chapters cover advancements in targeted therapy, where aptamers deliver personalized treatments with remarkable precision, minimizing side effects and maximizing efficacy. It highlights real-world applications, success stories, and the pursuit of more effective and humane cancer diagnosis and treatment.
The book is intended for clinicians and students.
